SureTrader Advertisement SureTrader
Home > Boards > US Listed > Biotechs > ImmunoCellular Therapeutics, Ltd. (IMUC)

totally agree with that

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
biomanbaba Member Profile
 Grandfathered Member
Followed By 210
Posts 14,251
Boards Moderated 1
Alias Born 02/04/01
160x600 placeholder
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/29/2016 4:26:03 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/30/2016 5:00:59 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/30/2016 4:41:00 PM
ImmunoCellular Therapeutics Announces 2015 Financial Results "PR Newswire (US)" - 3/30/2016 4:15:00 PM
ImmunoCellular Therapeutics to Report 2015 Financial Results on March 30, 2016 "PR Newswire (US)" - 3/29/2016 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/15/2016 4:02:27 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/15/2016 4:00:38 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/15/2016 3:57:50 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/15/2016 3:56:29 PM
ImmunoCellular Therapeutics to Present at ROTH Conference on March 16, 2016 "PR Newswire (US)" - 3/7/2016 6:00:00 AM
Cryoport Supports ImmunoCellular Therapeutics' 120-Site Phase III Clinical Trial With Cold Chain Logistics "PR Newswire (US)" - 3/3/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/2/2016 4:24:17 PM
ImmunoCellular Therapeutics Enters into Research Agreement with Stanford University to Advance Stem-to-T-Cell Program "PR Newswire (US)" - 2/16/2016 6:00:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/12/2016 8:08:59 AM
ImmunoCellular Therapeutics to Present at the BIO CEO & Investor Conference on February 8, 2016 "PR Newswire (US)" - 2/1/2016 6:00:00 AM
ImmunoCellular Therapeutics Enters into a Sponsored Research Agreement with The University of Maryland, Baltimore to Pursue M... "PR Newswire (US)" - 1/27/2016 6:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/20/2016 6:05:59 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/20/2016 6:04:11 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 1/20/2016 6:01:47 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/12/2016 1:08:37 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 12/30/2015 6:04:01 AM
ImmunoCellular Therapeutics Establishes Agreement with The Canadian Brain Tumour Consortium for ICT-107 Phase 3 Registrationa... "PR Newswire (US)" - 12/14/2015 6:00:00 AM
ImmunoCellular Therapeutics Establishes Agreement with Alliance Foundation Trials, LLC for ICT-107 Phase 3 Registrational Tri... "PR Newswire (US)" - 12/7/2015 6:00:00 AM
ImmunoCellular Therapeutics Establishes Agreement with EORTC for ICT-107 Phase 3 Registrational Trial in Glioblastoma "PR Newswire (US)" - 12/1/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/25/2015 6:20:17 AM
biomanbaba  Grandfathered Member Friday, 05/11/12 08:47:45 PM
Re: fm112 post# 984
Post # of 3484 
totally agree with that

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist